Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 339453
Gene Symbol: TMEM240
TMEM240
0.010 GeneticVariation phenotype BEFREE A systematic review of all previously reported SCA21 patients (n = 42) demonstrates that SCA21 is a relatively early-onset SCA (median onset age 18 years; range 1-61 years) with frequent non-cerebellar involvement, including hyporeflexia (69%), bradykinesia (65%), slow saccades (38%) and pyramidal signs (17%). 30522958 2019
Entrez Id: 7173
Gene Symbol: TPO
TPO
0.010 Biomarker phenotype BEFREE MSA is an adult-onset, sporadic, progressive parkinsonian syndrome characterised by the presence of akinesia, cerebellar dysfunction, autonomic failure and pyramidal signs. 30704970 2019
Entrez Id: 83636
Gene Symbol: C19orf12
C19orf12
0.010 GeneticVariation phenotype BEFREE Patients from 13 different families having progressive motor symptoms with irritative pyramidal signs and brain iron accumulation were screened for C19orf12 gene variants. 31804703 2019
Entrez Id: 6305
Gene Symbol: SBF1
SBF1
0.010 Biomarker phenotype BEFREE The novel SBF1 null mutation highlights distinct severe phenotypic manifestations, broadening the clinical spectrum of SBF1-related neuropathies: cerebellar and pyramidal signs evident in the first months of life with peripheral polyneuropathy emerging only toward the end of the first decade, together with unique MRI findings. 30039846 2018
Entrez Id: 3295
Gene Symbol: HSD17B4
HSD17B4
0.010 Biomarker phenotype BEFREE Genetic analysis of HSD17B4 should be considered in adult patients with cerebellar ataxia, peripheral neuropathy, and pyramidal signs in addition to sensorineural auditory disturbance since childhood. 28017249 2017
Entrez Id: 6712
Gene Symbol: SPTBN2
SPTBN2
0.010 Biomarker phenotype BEFREE To date, only two other SPTBN2 mutations with recessive pattern of inheritance causing SCAR14 (spinocerebellar ataxia, autosomal recessive 14) that manifest with developmental ataxia and cognitive impairment, or cerebellar ataxia, mental retardation, and pyramidal signs have been reported. 28636205 2017
Entrez Id: 4976
Gene Symbol: OPA1
OPA1
0.010 GeneticVariation phenotype BEFREE Human skin fibroblasts were isolated from a 48-year-old patient carrying compound heterozygous mutations (c.610+364G>A and c.1311A>G) in OPA1, responsible for early onset optic atrophy complicated by ataxia and pyramidal signs (Behr syndrome; OMIM #210000). 27879217 2016
Entrez Id: 22880
Gene Symbol: MORC2
MORC2
0.010 GeneticVariation phenotype BEFREE MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs. 26659848 2016
Entrez Id: 54974
Gene Symbol: THG1L
THG1L
0.010 GeneticVariation phenotype BEFREE Using whole exome sequencing, we identified homozygous p.Val55Ala in the THG1L (tRNA-histidine guanylyltransferase 1 like) gene in three siblings who presented with cerebellar signs, developmental delay, dysarthria, and pyramidal signs and had cerebellar atrophy on brain MRI. 27307223 2016
Entrez Id: 3316
Gene Symbol: HSPB2
HSPB2
0.010 Biomarker phenotype BEFREE Atypical features such as deafness and pyramidal signs were present in our cases adding new data to the large spectrum of HSP27-related phenotype. 25547330 2015
Entrez Id: 8988
Gene Symbol: HSPB3
HSPB3
0.010 Biomarker phenotype BEFREE Atypical features such as deafness and pyramidal signs were present in our cases adding new data to the large spectrum of HSP27-related phenotype. 25547330 2015
Entrez Id: 3315
Gene Symbol: HSPB1
HSPB1
0.010 Biomarker phenotype BEFREE Atypical features such as deafness and pyramidal signs were present in our cases adding new data to the large spectrum of HSP27-related phenotype. 25547330 2015
Entrez Id: 3798
Gene Symbol: KIF5A
KIF5A
0.010 Biomarker phenotype BEFREE Another 66 patients with HSP or CMT2 with pyramidal signs were sequenced for all exons of KIF5A by targeted resequencing. 25008398 2014
Entrez Id: 4747
Gene Symbol: NEFL
NEFL
0.010 GeneticVariation phenotype BEFREE Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs. 25583183 2014
Entrez Id: 101060233
Gene Symbol: OPN1MW3
OPN1MW3
0.010 Biomarker phenotype BEFREE These forms can present PSP or CBD-like clinical signs, with bulbar and/or extrabulbar pyramidal signs and cognitive impairment. 23546887 2013
Entrez Id: 2652
Gene Symbol: OPN1MW
OPN1MW
0.010 Biomarker phenotype BEFREE These forms can present PSP or CBD-like clinical signs, with bulbar and/or extrabulbar pyramidal signs and cognitive impairment. 23546887 2013
Entrez Id: 728458
Gene Symbol: OPN1MW2
OPN1MW2
0.010 Biomarker phenotype BEFREE These forms can present PSP or CBD-like clinical signs, with bulbar and/or extrabulbar pyramidal signs and cognitive impairment. 23546887 2013
Entrez Id: 23095
Gene Symbol: KIF1B
KIF1B
0.010 GeneticVariation phenotype BEFREE Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. 20806400 2010
Entrez Id: 3708
Gene Symbol: ITPR1
ITPR1
0.010 Biomarker phenotype BEFREE Clinical data of ten patients and brain MRI (available for six) showed that the phenotype substantially overlapped known SCA15 cases,but we also noted buccolingual dyskinesias, facial myokymias,and pyramidal signs never reported in SCA15. 20082166 2010
Entrez Id: 9587
Gene Symbol: MAD2L1BP
MAD2L1BP
0.010 GeneticVariation phenotype BEFREE Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. 20806400 2010
Entrez Id: 26278
Gene Symbol: SACS
SACS
0.010 GeneticVariation phenotype BEFREE With the collaboration of the clinical European and Mediterranean SPATAX network, we identified 15 families with 34 affected members presenting with ataxia and pyramidal signs or spasticity that were not linked to the ARSACS locus on chromosome 13. 17273843 2007
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.010 Biomarker phenotype BEFREE Larger expansions correlated with areflexia in SCA 2, with pyramidal signs in SCA 3 and with early visual impairment in SCA 7. 15876341 2005
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.010 GeneticVariation phenotype BEFREE Larger expansions correlated with areflexia in SCA 2, with pyramidal signs in SCA 3 and with early visual impairment in SCA 7. 15876341 2005
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.010 GeneticVariation phenotype BEFREE Larger expansions correlated with areflexia in SCA 2, with pyramidal signs in SCA 3 and with early visual impairment in SCA 7. 15876341 2005
Entrez Id: 4061
Gene Symbol: LY6E
LY6E
0.010 Biomarker phenotype BEFREE Larger expansions correlated with areflexia in SCA 2, with pyramidal signs in SCA 3 and with early visual impairment in SCA 7. 15876341 2005